Stress-induced pain: A target for the development of novel therapeutics

Journal of Pharmacology and Experimental Therapeutics

Volumn 351, Issue 2, 2014, Pages 327-335

  Johnson, Anthony C ^a   Greenwood Van Meerveld, Beverley ^a,b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMPA RECEPTOR; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DIZOCILPINE; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; GLUTAMATE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SIGMA 1 OPIATE RECEPTOR; SPIRONOLACTONE; TIAGABINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; [ 2 AMINO 4 [[[4 (CARBOXYMETHOXY) PHENYL](HYDROXY)METHYL](HYDROXY)PHOSPHORYL]BUTANOIC ACID],; [N (PIPERIDIN 1 YL) 5 (4 IODOPHENYL) 1 (2,4 DICHLOROPHENYL) 4 METHYL 1H PYRAZOLE 3 CARBOXAMIDE]; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NARCOTIC ANALGESIC AGENT;

BINDING AFFINITY; BRAIN REGION; CHRONIC PAIN; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOSTIMULATION; NERVE CELL; NERVE ENDING; NERVE STIMULATION; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN RECEPTOR; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SPINAL CORD DORSAL HORN; SPINAL GANGLION; STIMULUS RESPONSE; STRESS; ANIMAL; BRAIN; HUMAN; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY;

ANALGESICS, OPIOID; ANIMALS; BRAIN; CHRONIC PAIN; HUMANS; NEUROTRANSMITTER AGENTS; NOCICEPTORS; STRESS, PSYCHOLOGICAL;

EID: 84908143657     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.218065     Document Type: Review

References (135)

1. Alexander JK, DeVries AC, Kigerl KA, Dahlman JM, and Popovich PG (2009) Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav Immun 23:851-860.
2. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, and Harmar AJ; CGTP Collaborators (2013a) The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170:1459-1581.
3. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, and Harmar AJ; CGTP Collaborators (2013b) The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors. Br J Pharmacol 170:1652-1675.
4. Alexander SP, Mathie A, and Peters JA (2011) Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164(Suppl 1):S1-S324.
5. Almeida TF, Roizenblatt S, and Tufik S (2004) Afferent pain pathways: a neuroanatomical review. Brain Res 1000:40-56.
6. Arroyo-Novoa CM, Figueroa-Ramos MI, Miaskowski C, Padilla G, Stotts N, and Puntillo KA (2009) Acute wound pain: gaining a better understanding. Adv Skin Wound Care 22:373-380; quiz 381-382.
7. Asan E, Steinke M, and Lesch KP (2013) Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety. Histochem Cell Biol 139:785-813.
8. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, and Langer SZ (1998) International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291-313.
9. Bon K, Lantéri-Minet M, Michiels JF, and Menétrey D (1998) Cyclophosphamide cystitis as a model of visceral pain in rats: a c-fos and Krox-24 study at telencephalic levels, with a note on pituitary adenylate cyclase activating polypeptide (PACAP). Exp Brain Res 122:165-174.
10. Bouchard P and Quirion R (1997) [3H]1, 3-Di (2-tolyl) guanidine and [3H] (+) pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience 76:467-477.
11. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, and Enna SJ (2002) International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid (B) receptors: structure and function. Pharmacol Rev 54:247-264.
12. Braz J, Solorzano C, Wang X, and Basbaum AI (2014) Transmitting pain and itch messages: a contemporary view of the spinal cord circuits that generate gate control. Neuron 82:522-536.
13. Butler RK and Finn DP (2009) Stress-induced analgesia. Prog Neurobiol 88:184-202.
14. Buvanendran A (2013) Nonsteroidal Anti-inflammatory Drugs, in Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches (Buvanendran A, Deer TR, Gordin V, Kim PS, Leong MS, Panchal SJ, and Ray AL, eds, ed) pp 35-44, Springer, New York.
15. Buvanendran A and Lipman AG (2010) Nonsteroidal anti-inflammatory dugs and acetaminophen, in Bonica's Management of Pain, 4th ed (Ballantyne JC, Fishman SM, and Rathmell JP, eds) pp 1157-1171, Lippincott Williams & Wilkins, Philadelphia.
16. Crock LW, Kolber BJ, Morgan CD, Sadler KE, Vogt SK, Bruchas MR and Gereau RW IV (2012) Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain. J Neurosci 32:14217-14226.
17. da Costa Gomez TM and Behbehani MM (1995) An electrophysiological characterization of the projection from the central nucleus of the amygdala to the periaqueductal gray of the rat: the role of opioid receptors. Brain Res 689:21-31.
18. Davis-Taber R, Baker S, Lehto SG, Zhong C, Surowy CS, Faltynek CR, Scott VE, and Honore P (2008) Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states. J Pain 9:449-456.
19. Dina OA, Khasar SG, Alessandri-Haber N, Green PG, Messing RO, and Levine JD (2008) Alcohol-induced stress in painful alcoholic neuropathy. Eur J Neurosci 27:83-92.
20. Dong F, Xie W, Strong JA, and Zhang JM (2012) Mineralocorticoid receptor blocker eplerenone reduces pain behaviors in vivo and decreases excitability in small-diameter sensory neurons from local inflamed dorsal root ganglia in vitro. Anesthesiology 117:1102-1112.
21. Dong Z, Mao R, Han H, Cao J, and Xu L (2006) Morphine withdrawal modifies antinociceptive effects of acute morphine in rats. Biochem Biophys Res Commun 346:578-582.
22. Edvinsson L (2014) PACAP and its receptors in migraine pathophysiology. Br J Pharmacol DOI: 10.1111/bph.12772 [published ahead of print].
23. Eisenberg E and Peterson D (2010) Neuropathic pain pharmacotherapy, in Bonica's Management of Pain, 4th ed (Ballantyne JC, Fishman SM, and Rathmell JP, eds) pp 1194-1207, Lippincott Williams & Wilkins, Philadelphia.
24. Enna SJ and Bowery NG (2004) GABA (B) receptor alterations as indicators of physiological and pharmacological function. Biochem Pharmacol 68:1541-1548.
25. Evanson NK, Tasker JG, Hill MN, Hillard CJ, and Herman JP (2010) Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 151:4811-4819.
26. Fornasari D (2012) Pain mechanisms in patients with chronic pain. Clin Drug Investig 32(Suppl 1):45-52.
27. Gallagher JP, Orozco-Cabal LF, Liu J, and Shinnick-Gallagher P (2008) Synaptic physiology of central CRH system. Eur J Pharmacol 583:215-225.
28. Gorzalka BB, Hill MN, and Hillard CJ (2008) Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev 32:1152-1160.
29. Goudet C, Magnaghi V, Landry M, Nagy F, Gereau RW, IV, and Pin JP (2009) Metabotropic receptors for glutamate and GABA in pain. Brain Res Brain Res Rev 60:43-56.
30. Grace PM, Hutchinson MR, Maier SF, and Watkins LR (2014) Pathological pain and the neuroimmune interface. Nat Rev Immunol 14:217-231.
31. Gris G, Merlos M, Vela JM, Zamanillo D, and Portillo-Salido E (2014) S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund's adjuvant models in mice. Behav Pharmacol 25:226-235.
32. Gu X, Peng L, Yang D, Ma Q, Zheng Y, Liu C, Zhu B, Song L, Sun X, and Ma Z (2011) The respective and interaction effects of spinal GRs and MRs on radicular pain induced by chronic compression of the dorsal root ganglion in the rat. Brain Res 1396:88-95.
33. Gu X, Wang S, Yang L, Sung B, Lim G, Mao J, Zeng Q, Chang Y, and Mao J (2007) Time-dependent effect of epidural steroid on pain behavior induced by chronic compression of dorsal root ganglion in rats. Brain Res 1174:39-46.
34. Guitart X, Codony X, and Monroy X (2004) Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl) 174:301-319.
35. Gunn BG, Cunningham L, Mitchell SG, Swinny JD, Lambert JJ, and Belelli D (2014) GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response. Front Neuroendocrinol DOI: 10.1016/j.yfrne.2014.06.001 [published ahead of print].
36. Haller J, Mikics E, and Makara GB (2008) The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 29:273-291.
37. Hammes SR and Levin ER (2011) Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology 152:4489-4495.
38. Han ZL, Fang Q, Wang ZL, Li XH, Li N, Chang XM, Pan JX, Tang HZ, and Wang R (2014) Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m) VD-hemopressin (a)], an N-terminally extended hemopressin peptide. J Pharmacol Exp Ther 348:316-323.
39. Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, and Said SI (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166:4-17.
40. Hayashi T, Tsai SY, Mori T, Fujimoto M, and Su TP (2011) Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 15:557-577.
41. Heinricher MM, Tavares I, Leith JL, and Lumb BM (2009) Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev 60:214-225.
42. Herman JP and Cullinan WE (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84.
43. Hill MN and McEwen BS (2010) Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry 34:791-797.
44. Hong S, Zheng G, Wu X, Snider NT, Owyang C, and Wiley JW (2011) Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat. Gastroenterology 140:627-637.e4.
45. Hu JH, Yang N, Ma YH, Zhou XG, Jiang J, Duan SH, Mei ZT, Fei J, and Guo LH (2003) Hyperalgesic effects of gamma-aminobutyric acid transporter I in mice. J Neurosci Res 73:565-572.
46. Hubbard CS, Labus JS, Bueller J, Stains J, Suyenobu B, Dukes GE, Kelleher DL, Tillisch K, Naliboff BD, and Mayer EA (2011) Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain. J Neurosci 31:12491-12500.
47. Inturrisi CE and Lipman AG (2010) Opioid analgesics, in Bonica's Management of Pain, 4th ed (Ballantyne JC, Fishman SM, and Rathmell JP, eds) pp 1172-1187, Lippincott Williams & Wilkins, Philadelphia.
48. Institute of Medicine (2011) Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, The National Academies Press, Washington, DC.
49. Jackson KC and Argoff CE (2010) Skeletal muscle relaxants and analgesic balms, in Bonica's Management of Pain, 4th ed (Ballantyne JC, Fishman SM, and Rathmell JP, eds) pp 1188-1193, Lippincott Williams & Wilkins, Philadelphia.
50. Jaggi AS and Singh N (2011) Role of different brain areas in peripheral nerve injuryinduced neuropathic pain. Brain Res 1381:187-201.
51. Ji G and Neugebauer V (2007) Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J Neurophysiol 97:3893-3904.
52. Ji G and Neugebauer V (2008) Pro- and anti-nociceptive effects of corticotropinreleasing factor (CRF) in central amygdala neurons are mediated through different receptors. J Neurophysiol 99:1201-1212.
53. Ji XT, Qian NS, Zhang T, Li JM, Li XK, Wang P, Zhao DS, Huang G, Zhang L, and Fei Z, et al. (2013) Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model. PLoS One 8:e60733.
54. Jinzenji A, Sogawa C, Miyawaki T, Wen XF, Yi D, Ohyama K, Kitayama S, Sogawa N, and Morita K (2014) Antiallodynic action of 1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methyoxyphenyl)-4-piperidinol (NNC05-2090), a betaine/GABA transporter inhibitor. J Pharmacol Sci 125:217-226.
55. Johnson AC and Greenwood-Van Meerveld B (2012) Evidence to support the nongenomic modulation of the HPA axis. J Steroids Horm Sci 3:e109.
56. Johnson LR, Farb C, Morrison JH, McEwen BS, and LeDoux JE (2005) Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. Neuroscience 136:289-299.
57. Julio-Pieper M, Flor PJ, Dinan TG, and Cryan JF (2011) Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev 63:35-58.
58. Karst H, Berger S, Turiault M, Tronche F, Schütz G, and Joëls M (2005) Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 102:19204-19207.
59. Kataoka K, Hara K, Haranishi Y, Terada T, and Sata T (2013) The antinociceptive effect of SNAP5114, a gamma-aminobutyric acid transporter-3 inhibitor, in rat experimental pain models. Anesth Analg 116:1162-1169.
60. Kim MA and Jeong KY (2013) Chronological changes of mechanical allodynia and spinal microglia activation by an intrathecal injection of MK-801. Neuroreport 24:585-589.
61. Kolber BJ, Montana MC, Carrasquillo Y, Xu J, Heinemann SF, Muglia LJ, and Gereau RW, IV (2010) Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior. J Neurosci 30:8203-8213.
62. Lampe A, Doering S, Rumpold G, Sölder E, Krismer M, Kantner-Rumplmair W, Schubert C, and Söllner W (2003) Chronic pain syndromes and their relation to childhood abuse and stressful life events. J Psychosom Res 54:361-367.
63. Liu GX, Cai GQ, Cai YQ, Sheng ZJ, Jiang J, Mei Z, Wang ZG, Guo L, and Fei J (2007) Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology 32:1531-1539.
64. Liu NJ, Schnell SA, Schulz S, Wessendorf MW, and Gintzler AR (2011) Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition. J Pharmacol Exp Ther 336:328-335.
65. Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, and Weigel NL, et al. (2006) International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev 58:782-797.
66. Luongo L, Maione S, and Di Marzo V (2014) Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions. Eur J Neurosci 39:401-408.
67. Maizels M, Aurora S, and Heinricher M (2012) Beyond neurovascular: migraine as a dysfunctional neurolimbic pain network. Headache 52:1553-1565.
68. McKenna NJ and O'Malley BW (2005) Teaching resources. An interactive course in nuclear receptor signaling: concepts and models. Sci STKE 2005:tr22.
69. McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, Park KM, Liberzon I, Sen A, and Gracely RH, et al. (2006) Cerebrospinal fluid corticotropinreleasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 31:2776-2782.
70. Mei YY and Li JS (2013) Involvements of stress hormones in the restraint-induced conditioned place preference. Behav Brain Res 256:662-668.
71. Missig G, Roman CW, Vizzard MA, Braas KM, Hammack SE, and May V (2014) Parabrachial nucleus (PBn) pituitary adenylate cyclase activating polypeptide (PACAP) signaling in the amygdala: implication for the sensory and behavioral effects of pain. Neuropharmacology 86 C: 38-48.
72. Mitra R and Sapolsky RM (2008) Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci USA 105:5573-5578.
73. Mora F, Segovia G, Del Arco A, de Blas M, and Garrido P (2012) Stress, neurotransmitters, corticosterone and body-brain integration. Brain Res 1476:71-85.
74. Munro G, Hansen RR, and Mirza NR (2013) GABA (A) receptor modulation: potential to deliver novel pain medicines? Eur J Pharmacol 716:17-23.
75. Murinson BB (2013) The role of antidepressants in the treatment of chronic pain, in Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches (Buvanendran A, Deer TR, Gordin V, Kim PS, Leong MS, Panchal SJ, and Ray AL, eds) pp 45-51, Springer, New York.
76. Mustafa T (2013) Pituitary adenylate cyclase-activating polypeptide (PACAP): a master regulator in central and peripheral stress responses. Adv Pharmacol 68:445-457.
77. Myers B, Dittmeyer K, and Greenwood-Van Meerveld B (2007) Involvement of amygdaloid corticosterone in altered visceral and somatic sensation. Behav Brain Res 181:163-167.
78. Myers B and Greenwood-Van Meerveld B (2007) Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol 292:G1622-G1629.
79. Myers B and Greenwood-Van Meerveld B (2010) Divergent effects of amygdala glucocorticoid and mineralocorticoid receptors in the regulation of visceral and somatic pain. Am J Physiol Gastrointest Liver Physiol 298:G295-G303.
80. Myers B and Greenwood-Van Meerveld B (2012) Differential involvement of amygdala corticosteroid receptors in visceral hyperalgesia following acute or repeated stress. Am J Physiol Gastrointest Liver Physiol 302:G260-G266.
81. Navratilova E, Xie JY, King T, and Porreca F (2013) Evaluation of reward from pain relief. Ann N Y Acad Sci 1282:1-11.
82. Nicholson BD (2013) Anticonvulsant medications for treatment of neuropathic and "functional" pain, in Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches (Buvanendran A, Deer TR, Gordin V, Kim PS, Leong MS, Panchal SJ, and Ray AL, eds) pp 53-59, Springer, New York.
83. Ohsawa M, Brailoiu GC, Shiraki M, Dun NJ, Paul K, and Tseng LF (2002) Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse. Pain 100:27-34.
84. Olsen RW and Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60:243-260.
85. Ossipov MH, Lai J, Malan TP, Jr, and Porreca F (2000) Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci 909:12-24.
86. Palazzo E, de Novellis V, Rossi F, and Maione S (2014a) Supraspinal metabotropic glutamate receptor subtype 8: a switch to turn off pain. Amino Acids 46:1441-1448.
87. Palazzo E, Marabese I, de Novellis V, Rossi F, and Maione S (2014b) Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond. Eur J Neurosci 39:444-454.
88. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, and Mackie K, et al. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588-631.
89. Prager EM, Brielmaier J, Bergstrom HC, McGuire J, and Johnson LR (2010) Localization of mineralocorticoid receptors at mammalian synapses. PLoS One 5:e14344.
90. Price JL (1999) Prefrontal cortical networks related to visceral function and mood. Ann N Y Acad Sci 877:383-396.
91. Racine M, Tousignant-Laflamme Y, Kloda LA, Dion D, Dupuis G, and Choinière M (2012) A systematic literature review of 10 years of research on sex/gender and pain perception-part 2: do biopsychosocial factors alter pain sensitivity differently in women and men? Pain 153:619-635.
92. Radley JJ, Anderson RM, Hamilton BA, Alcock JA, and Romig-Martin SA (2013) Chronic stress-induced alterations of dendritic spine subtypes predict functional decrements in an hypothalamo-pituitary-adrenal-inhibitory prefrontal circuit. J Neurosci 33:14379-14391.
93. Rea K, Ford GK, Olango WM, Harhen B, Roche M, and Finn DP (2014a) Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. Eur J Neurosci 39:435-443.
94. Rea K, Olango WM, Okine BN, Madasu MK, McGuire IC, Coyle K, Harhen B, Roche M, and Finn DP (2014b) Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli. Pain 155:69-79.
95. Reichling DB, Green PG, and Levine JD (2013) The fundamental unit of pain is the cell. Pain 154(Suppl 1):S2-S9.
96. Reichling DB and Levine JD (2009) Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 32:611-618.
97. Reul JM and de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117:2505-2511.
98. Reyes BA, Carvalho AF, Vakharia K, and Van Bockstaele EJ (2011) Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal centers. Exp Neurol 230:96-105.
99. Saab CY (2012) Pain-related changes in the brain: diagnostic and therapeutic potentials. Trends Neurosci 35:629-637.
100. Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M, and Fukudo S (2004) Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 53:958-964.
101. Sapolsky RM, McEwen BS, and Rainbow TC (1983) Quantitative autoradiography of [3H]corticosterone receptors in rat brain. Brain Res 271:331-334.
102. Scarinci IC, McDonald-Haile J, Bradley LA, and Richter JE (1994) Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. Am J Med 97:108-118.
103. Schaible HG, Ebersberger A, and Natura G (2011) Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines. Arthritis Res Ther 13:210.
104. Schulkin J, Gold PW, and McEwen BS (1998) Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 23:219-243.
105. Shen S, Gehlert DR, and Collier DA (2013) PACAP and PAC1 receptor in brain development and behavior. Neuropeptides 47:421-430.
106. Shepard JD, Barron KW, and Myers DA (2000) Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861:288-295.
107. Shimizu T, Katahira M, Sugawara H, Inoue K, and Miyata A (2004) Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord. Regul Pept 123:117-122.
108. Smith JS, Schindler AG, Martinelli E, Gustin RM, Bruchas MR, and Chavkin C (2012) Stress-induced activation of the dynorphin/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci 32:1488-1495.
109. Staud R (2012) Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother 12:577-585.
110. Stemkowski PL and Smith PA (2012) Sensory neurons, ion channels, inflammation and the onset of neuropathic pain. Can J Neurol Sci 39:416-435.
111. Sun Y, Zhang W, Liu Y, Liu X, Ma Z, and Gu X (2014) Intrathecal injection of JWH015 attenuates remifentanil-induced postoperative hyperalgesia by inhibiting activation of spinal glia in a rat model. Anesth Analg 118:841-853.
112. Sun YE, Peng L, Sun X, Bo J, Yang D, Zheng Y, Liu C, Zhu B, Ma Z, and Gu X (2012) Intrathecal injection of spironolactone attenuates radicular pain by inhibition of spinal microglia activation in a rat model. PLoS One 7:e39897.
113. Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, and Schoepp DD (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 4:131-144.
114. Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, and Zinsmeister AR (2009) Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol 296:G1299-G1306.
115. Takasaki I, Kurihara T, Saegusa H, Zong S, and Tanabe T (2005) Effects of glucocorticoid receptor antagonists on allodynia and hyperalgesia in mouse model of neuropathic pain. Eur J Pharmacol 524:80-83.
116. Tao YX (2012) AMPA receptor trafficking in inflammation-induced dorsal horn central sensitization. Neurosci Bull 28:111-120.
117. Thoeringer CK, Erhardt A, Sillaber I, Mueller MB, Ohl F, Holsboer F, and Keck ME (2010) Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. J Psychopharmacol 24:733-743.
118. Timmermans W, Xiong H, Hoogenraad CC, and Krugers HJ (2013) Stress and excitatory synapses: from health to disease. Neuroscience 248:626-636.
119. Tran L, Schulkin J, and Greenwood-Van Meerveld B (2014) Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain. Neuropsychopharmacology DOI: 10.1038/npp.2014.117 [published ahead of print].
120. Trescot A (2013) Clinical use of opioids, in Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches (Buvanendran A, Deer TR, Gordin V, Kim PS, Leong MS, Panchal SJ, and Ray AL, eds) pp 99-110, Springer, New York.
121. Vaughn LK, Mantsch JR, Vranjkovic O, Stroh G, Lacourt M, Kreutter M, and Hillard CJ (2012) Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience 204:117-124.
122. Vidal-Torres A, Fernández-Pastor B, Carceller A, Vela JM, Merlos M, and Zamanillo D (2014) Effects of the selective sigma-1 receptor antagonist S1RA on formalininduced pain behavior and neurotransmitter release in the spinal cord in rats. J Neurochem 129:484-494.
123. Vilar B, Busserolles J, Ling B, Laffray S, Ulmann L, Malhaire F, Chapuy E, Aissouni Y, Etienne M, and Bourinet E, et al. (2013) Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptor. J Neurosci 33:18951-18965.
124. Vyas A, Mitra R, Shankaranarayana Rao BS, and Chattarji S (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22:6810-6818.
125. Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G, Yang L, and Mao J (2004) Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 24:8595-8605.
126. Wang S, Lim G, Zeng Q, Sung B, Yang L, and Mao J (2005) Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 25:488-495.
127. Widgerow AD and Kalaria S (2012) Pain mediators and wound healing-establishing the connection. Burns 38:951-959.
128. Wilder-Smith CH (2011) The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. Gut 60:1589-1599.
129. Woolf CJ and Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769.
130. Woolley CS, Gould E, and McEwen BS (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 531:225-231.
131. Xu YF, Cai YQ, Cai GQ, Jiang J, Sheng ZJ, Wang ZG, and Fei J (2008) Hypoalgesia in mice lacking GABA transporter subtype 1. J Neurosci Res 86:465-470.
132. Yarushkina NI, Bagaeva TR, and Filaretova LP (2009) Analgesic actions of corticotropin-releasing factor (CRF) on somatic pain sensitivity: involvement of glucocorticoid and CRF-2 receptors. Neurosci Behav Physiol 39:819-823.
133. Zamanillo D, Romero L, Merlos M, and Vela JM (2013) Sigma 1 receptor: a new therapeutic target for pain. Eur J Pharmacol 716:78-93.
134. Zeilhofer HU, Wildner H, and Yévenes GE (2012) Fast synaptic inhibition in spinal sensory processing and pain control. Physiol Rev 92:193-235.
135. Zhou Q, Wang J, Zhang X, Zeng L, Wang L, and Jiang W (2013) Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain. Eur J Pharmacol 718:17-23.